Humacyte to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ

April 28, 2023

https://www.globenewswire.com/news-release/2023/04/28/2657366/0/en/Humacyte-to-Present-at-the-H-C-Wainwright-BioConnect-Investor-Conference-at-NASDAQ.html

DURHAM, N.C., April 28, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq:HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, and Dale Sander, Chief Financial Officer, will participate in a company presentation and one-on-one investor meetings at the H.C. Wainwright BioConnect Investor Conference, which will take place in-person at NASDAQ World Headquarters on May 2nd, 2023.

Read more at globenewswire.com

Related news for (HUMA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.